Testing effectiveness (Phase 2)Study completedNCT01526057
What this trial is testing
A Pharmacokinetic/Pharmacodynamic Study Comparing PF-05280586 To Rituximab In Subjects With Active Rheumatoid Arthritis With An Inadequate Response To TNF Inhibitors (REFLECTIONS B328-01)
Who this might be right for
Rheumatoid Arthritis
Pfizer 220